Amy Vandenberg - Net Worth and Insider Trading
Amy Vandenberg Net Worth
The estimated net worth of Amy Vandenberg is at least $11,959 dollars as of 2024-09-23. Amy Vandenberg is the Chief Clinical & Reg Officer of Obalon Therapeutics Inc and owns about 3,921 shares of Obalon Therapeutics Inc (OBLN) stock worth over $11,959. Details can be seen in Amy Vandenberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amy Vandenberg has not made any transactions after 2019-08-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Amy Vandenberg
Amy Vandenberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amy Vandenberg owns 2 companies in total, including Obalon Therapeutics Inc (OBLN) , and Reshape Lifesciences Inc (RSLS) .
Click here to see the complete history of Amy Vandenberg’s form 4 insider trades.
Insider Ownership Summary of Amy Vandenberg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OBLN | Obalon Therapeutics Inc | 2020-01-24 | Chief Clinical & Reg Officer |
| RSLS | Reshape Lifesciences Inc | 2016-10-05 | VP of Reg. and Clin. Affairs |
Amy Vandenberg Latest Holdings Summary
Amy Vandenberg currently owns a total of 1 stock. Amy Vandenberg owns 3,921 shares of Obalon Therapeutics Inc (OBLN) as of August 6, 2019, with a value of $11,959.
Latest Holdings of Amy Vandenberg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OBLN | Obalon Therapeutics Inc | 2019-08-06 | 3,921 | 3.05 | 11,959 |
Holding Weightings of Amy Vandenberg
Amy Vandenberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Amy Vandenberg has made a total of 0 transactions in Obalon Therapeutics Inc (OBLN) over the past 5 years. The most-recent trade in Obalon Therapeutics Inc is the acquisition of 833 shares on August 6, 2019, which cost Amy Vandenberg around $10,000.
Insider Trading History of Amy Vandenberg
- 1
Amy Vandenberg Trading Performance
GuruFocus tracks the stock performance after each of Amy Vandenberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amy Vandenberg is -43.38%. GuruFocus also compares Amy Vandenberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amy Vandenberg within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Amy Vandenberg's insider trading performs compared to the benchmark.
Performance of Amy Vandenberg
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -43.38 | | | | | |
| Relative Return to S&P 500(%) | -46.74 | | | | | |
Amy Vandenberg Ownership Network
Amy Vandenberg Owned Company Details
What does Obalon Therapeutics Inc do?
Who are the key executives at Obalon Therapeutics Inc?
Amy Vandenberg is the Chief Clinical & Reg Officer of Obalon Therapeutics Inc. Other key executives at Obalon Therapeutics Inc include director & President & CEO & Exec Chairman Andrew P Rasdal , Chief Financial Officer Nooshin Hussainy , and Chief Technology Officer Mark Brister .
Obalon Therapeutics Inc (OBLN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Obalon Therapeutics Inc (OBLN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Obalon Therapeutics Inc (OBLN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Obalon Therapeutics Inc (OBLN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Obalon Therapeutics Inc Insider Transactions
Amy Vandenberg Mailing Address
Above is the net worth, insider trading, and ownership report for Amy Vandenberg. You might contact Amy Vandenberg via mailing address: C/o Obalon Therapeutics, Inc., 5421 Avenida Encinas, Suite F, Carlsbad Ca 92008.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
